New design and features of Quell 2.0 NeuroMetrix focused largely on two things to differentiate version 2.0: make the device smaller, and more functional with the mobile app for iOS and Android. The ...

Neurometrix has received FDA clearance for a new smartphone-controlled version of Quell, its wearable for pain relief, the company announced last week. Like its predecessor, the device will use nerve ...

A Massachusetts company is touting a wearable device that it says can alleviate chronic pain, offering a high-tech alternative to opioids. Quell is a drug-free device built by Waltham, Mass.-based ...

The Quell ® neuromodulation device (NeuroMetrix) has received the Food and Drug Administration De Novo authorization for use as an aid in reducing the symptoms of fibromyalgia in adults with high pain ...

The Quell Watch app gives a Quell user the ability to control and monitor their pain relief from their Apple Watch® Quell is a wearable, transcutaneous electrical nerve stimulation (TENS) device for ...

WOBURN, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has submitted a De Novo request to the U.S. Food and Drug Administration (FDA) for Quell as a ...

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that Quell ® Wearable Pain Relief Technology™ will be featured for the second year in a row at the American ...

WOBURN, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NURO) today announced U.S. Food and Drug Administration (FDA) De Novo authorization to market the Quell neuromodulation device as an ...

Being “drug-free” usually references illegal substance abuse, but prescriptions for chronic pain can lead to damaging dependency as well. For those eager to try a pain reliever that doesn’t require ...